ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less severe disease.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body's immune ...

Researchers from the Epigenetics and Immune Disease Laboratory at the Josep Carreras Leukaemia Research Institute in ...

PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON ITS MASITINIB PLATFORMParis, January 29, 2025, 7pm CETAB Science SA (Euronext - FR0010557264 - AB) ...